Abstract
An international meeting on scalp disorders was recently held in Rome. Psoriasis, seborrheic dermatitis, sebopsoriasis and primary cicatricial alopecias were the main topics. In this circumstance the results of the clinical trials in scalp psoriasis with a new fixed combination containing calcipotriene 50 μg/g and betamethasone (0.5 mg/g) as dipropionate in lipophilic gel (Xamiol®) were shown. Calcipotriene plus betamethasone dipropionate gel is a fast-acting, very efficacious, safe, oncedaily treatment for scalp psoriasis ranging from mild to very severe. It is more efficacious than calcipotriene, betamethasone dipropionate and the gel vehicle. The safety profile is similar to that of betamethasone dipropionate and better than calcipotriol. Two 52-week studies have shown that calcipotriene plus betamethasone dipropionate gel can be safely used longterm.
| Original language | Italian |
|---|---|
| Pages (from-to) | 71-81 |
| Number of pages | 11 |
| Journal | Journal of Plastic Dermatology |
| Volume | 6 |
| Issue number | 1 |
| Publication status | Published - 2010 |
Fingerprint
ASJC Scopus subject areas
- Dermatology
Cite this
Patologie del cuoio capelluto. / Di Maio, Antonio; Abeni, Damiano; Altomare, Gianfranco; Berardesca, Enzo; Pinton, Piergiacomo Calzavara; De Simone, Clara; Giannetti, Alberto; Gisondi, Paolo; Lotti, Torello; Piaserico, Stefano; Saraceno, Rosita; Vena, Gino Antonio.
In: Journal of Plastic Dermatology, Vol. 6, No. 1, 2010, p. 71-81.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Patologie del cuoio capelluto
AU - Di Maio, Antonio
AU - Abeni, Damiano
AU - Altomare, Gianfranco
AU - Berardesca, Enzo
AU - Pinton, Piergiacomo Calzavara
AU - De Simone, Clara
AU - Giannetti, Alberto
AU - Gisondi, Paolo
AU - Lotti, Torello
AU - Piaserico, Stefano
AU - Saraceno, Rosita
AU - Vena, Gino Antonio
PY - 2010
Y1 - 2010
N2 - An international meeting on scalp disorders was recently held in Rome. Psoriasis, seborrheic dermatitis, sebopsoriasis and primary cicatricial alopecias were the main topics. In this circumstance the results of the clinical trials in scalp psoriasis with a new fixed combination containing calcipotriene 50 μg/g and betamethasone (0.5 mg/g) as dipropionate in lipophilic gel (Xamiol®) were shown. Calcipotriene plus betamethasone dipropionate gel is a fast-acting, very efficacious, safe, oncedaily treatment for scalp psoriasis ranging from mild to very severe. It is more efficacious than calcipotriene, betamethasone dipropionate and the gel vehicle. The safety profile is similar to that of betamethasone dipropionate and better than calcipotriol. Two 52-week studies have shown that calcipotriene plus betamethasone dipropionate gel can be safely used longterm.
AB - An international meeting on scalp disorders was recently held in Rome. Psoriasis, seborrheic dermatitis, sebopsoriasis and primary cicatricial alopecias were the main topics. In this circumstance the results of the clinical trials in scalp psoriasis with a new fixed combination containing calcipotriene 50 μg/g and betamethasone (0.5 mg/g) as dipropionate in lipophilic gel (Xamiol®) were shown. Calcipotriene plus betamethasone dipropionate gel is a fast-acting, very efficacious, safe, oncedaily treatment for scalp psoriasis ranging from mild to very severe. It is more efficacious than calcipotriene, betamethasone dipropionate and the gel vehicle. The safety profile is similar to that of betamethasone dipropionate and better than calcipotriol. Two 52-week studies have shown that calcipotriene plus betamethasone dipropionate gel can be safely used longterm.
KW - Calcipotriene plus betamethasone dipropionate gel
KW - Psoriasis
KW - Scalp disorders
UR - http://www.scopus.com/inward/record.url?scp=77954500304&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954500304&partnerID=8YFLogxK
M3 - Articolo
AN - SCOPUS:77954500304
VL - 6
SP - 71
EP - 81
JO - Journal of Plastic Dermatology
JF - Journal of Plastic Dermatology
SN - 2035-0686
IS - 1
ER -